The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plum, J.
Right arrow Articles by Leclercq, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plum, J.
Right arrow Articles by Leclercq, G.

The Journal of Immunology, Vol 150, Issue 7 2706-2716, Copyright © 1993 by American Association of Immunologists


ARTICLES

Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture

J Plum, M De Smedt and G Leclercq
Department of Bacteriology, Virology and Immunology, University Hospital Gent, Belgium.

Addition of human rIL-7 to fetal thymic organ culture started at day 13, 14, or 15 did not influence the number of cells generated during a 12-day culture period. However, the IL-7 treatment resulted in a preferential expansion of cells with a phenotype characteristic for cells at an early step of differentiation. The cells were CD4-CD8-CD3- CD2- and SCA-1+. Analysis of the coordinate expression of CD44 and CD25 on these cells showed that the majority of the cells were either CD44+CD25- or CD44+CD25intermediate. TCR-alpha beta cells were present but in a significantly lower number as compared to the control cultures. The cell number of TCR-gamma delta cells was increased. All these effects were moderate after 6 days, but unequivocal after 12 days of culture. Treatment of the fetal organ culture with mAb-neutralizing murine IL-7 resulted in an inhibition of the proliferation of the fetal thymocytes. No particular subset studied was preferentially inhibited. By using a model of reconstitution of 14-day embryonic thymuses depleted of thymocytes by deoxyguanosine and reconstituted with fetal day 13 liver cells and set up in organ culture with or without IL-7, it was shown in a clear cut way that IL-7 indeed promotes expansion of the early precursor cells and TCR-gamma delta cells, but prevents the generation of TCR-alpha beta cells. In addition, reconstitution experiments were set up in the presence of mAb-neutralizing murine IL- 7. This treatment resulted in the inhibition of the growth of the fetal thymocytes without inhibiting preferentially a particular subset. These data indicate that IL-7 acts at an early step of T cell differentiation and plays a role to expand precursor cells, but prevents this population from additional differentiation towards the TCR-alpha beta pathways, whereas the differentiation towards TCR-gamma delta cells is not influenced or even enhanced.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Huang, K. P. Garrett, R. Pelayo, J. C. Zuniga-Pflucker, H. T. Petrie, and P. W. Kincade
Propensity of Adult Lymphoid Progenitors to Progress to DN2/3 Stage Thymocytes with Notch Receptor Ligation
J. Immunol., October 15, 2005; 175(8): 4858 - 4865.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. El Kassar, P. J. Lucas, D. B. Klug, M. Zamisch, M. Merchant, C. V. Bare, B. Choudhury, S. O. Sharrow, E. Richie, C. L. Mackall, et al.
A dose effect of IL-7 on thymocyte development
Blood, September 1, 2004; 104(5): 1419 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Middlebrook, C. Martina, Y. Chang, R. J. Lukas, and D. DeLuca
Effects of Nicotine Exposure on T Cell Development in Fetal Thymus Organ Culture: Arrest of T Cell Maturation
J. Immunol., September 15, 2002; 169(6): 2915 - 2924.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Chung, L. Barbara-Burnham, L. Barsky, and K. Weinberg
Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation
Blood, September 1, 2001; 98(5): 1601 - 1606.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Kang, M. Coles, and D. H. Raulet
Defective Development of {gamma}/{delta} T Cells in Interleukin 7 Receptor–deficient Mice Is Due to Impaired Expression of T Cell Receptor {gamma} Genes
J. Exp. Med., October 4, 1999; 190(7): 973 - 982.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Hirayama, Y. Aiba, K. Ikebuchi, S. Sekiguchi, and M. Ogawa
Differentiation in Culture of Murine Primitive Lymphohematopoietic Progenitors Toward T-Cell Lineage
Blood, June 15, 1999; 93(12): 4187 - 4195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Laky, L. Lefrancois, U. von Freeden-Jeffry, R. Murray, and L. Puddington
The Role of IL-7 in Thymic and Extrathymic Development of TCR{gamma}{delta} Cells
J. Immunol., July 15, 1998; 161(2): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Varas, A. Vicente, R. Sacedon, and A. G. Zapata
Interleukin-7 Influences the Development of Thymic Dendritic Cells
Blood, July 1, 1998; 92(1): 93 - 100.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Q. Lin, C. Dong, and M. D. Cooper
Impairment of  T and B Cell Development by Treatment with a Type I Interferon
J. Exp. Med., January 5, 1998; 187(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yasuda, I. Nishijima, S. Watanabe, K.-i. Arai, A. Zlotnik, and T. A. Moore
Human Granulocyte-Macrophage Colony-Stimulating Factor (hGM-CSF) Induces Inhibition of Intrathymic T-Cell Development in hGM-CSF Receptor Transgenic Mice
Blood, February 15, 1997; 89(4): 1349 - 1356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.